Q&A with Dr Chelsee Jensen: FDA Policy Shifts, Biosimilar Development Hurdles, and Market Access in 2026
Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist and pharmaceutical formulary manager at Mayo Clinic, shared her insights on future biosimilar development amidst recent FDA approvals and policy changes. In an interview with The Center for …